Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:36 AM
Ignite Modification Date:
2025-12-25 @ 4:36 AM
NCT ID:
NCT01523418
Eligibility Criteria:
Inclusion Criteria:
* Adult patients of either sex, undergoing elective THR/TKR, in whom, Rivaroxaban is given for thromboprophylaxis
* Patients willing to give a written informed consent
Exclusion Criteria:
* Exclusion criteria must be read in conjunction with the local product information
* Patients on UFH / LMWH therapy, fondaparinux and vitamin K antagonists are not eligible.
* Patients with history of hypersensitivity to active ingredients or excipient :cellulose microcrystalline, croscarmellose sodium, lactose monohydrate, magnesium stearate, sodium lauryl sulfate
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01523418
Study Brief:
Protocol Section:
NCT01523418